Back to FRANKLIN TEMPLETON INC FRANKLIN TEMPLETON INC

MRNSMRNS
17 quarters

Position history for FRANKLIN TEMPLETON INCFRANKLIN TEMPLETON INC's holdings in MARINUS PHARMACEUTICALS INC

No. Franklin Templeton exited its MRNS (Marinus Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 4,713,014 shares worth $8.5M. Franklin Templeton first reported MRNS in Q4 2020 and held it in 16 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$4.4M

Total Shares Change

-357,200

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q3
Increased
4.7M
+34.9%
$8.5M0.0%—
36
2024-Q2
Decreased
3.5M
0.0%
$4.1M0.0%—
0
2024-Q1
Decreased
3.5M
-8.9%
$31.6M0.0%—
0
2023-Q4
Increased
3.8M
+1.3%
$41.7M0.0%—
29
2023-Q3
Increased
3.8M
+187.4%
$30.5M0.0%—
46
2023-Q2
Increased
1.3M
+28.4%
$14.3M0.0%—
35
2023-Q1
Increased
1M
+134.4%
$7.1M0.0%—
44
2022-Q4
Unchanged
437,700
0.0%
$1.7M0.0%—
0
2022-Q3
Unchanged
437,700
0.0%
$2.9M0.0%—
0
2022-Q2
Increased
437,700
+22.5%
$2.1M0.0%—
31
2022-Q1
Unchanged
357,200
0.0%
$3.3M0.0%—
0
2021-Q4
Unchanged
357,200
0.0%
$4.2M0.0%—
0
2021-Q3
Unchanged
357,200
0.0%
$4.1M0.0%—
0
2021-Q2
Unchanged
357,200
0.0%
$6.4M0.0%—
0
2021-Q1
Unchanged
357,200
0.0%
$5.5M0.0%—
0
2020-Q4
New
357,200
-
$4.4M0.0%—
37

Other major holders of MRNS: Avoro Capital Advisors LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used